Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral versus intravenous ibuprofen for closure of patent ductus arteriosus in very low birth weight preterm infants
2010-018771-23Phase 4Active
- Sponsor
- Ospedale Santa Croce e Carle
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ibuprofen in patent ductus arteriosus (PDA) (2 arms), sponsored by Ospedale Santa Croce e Carle. Primary endpoint: Equivalent efficacy of oral and intravenous ibuprofen on PDA closure. Started Feb 2010; status: active.
02
Drugs
ibuprofen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on 2010-018771-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018771-23.